These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9039616)

  • 1. Preliminary evaluation of a polyethyleneglycol-stabilized manganese-substituted hydroxylapatite as an intravascular contrast agent for MR angiography.
    Adzamli K; Dorshow RB; Hynes MR; Li D; Nosco DL; Adams MD
    J Magn Reson Imaging; 1997; 7(1):204-8. PubMed ID: 9039616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of polyethyleneglycol-stabilized, manganese-substituted hydroxylapatite (MnHA-PEG). A potential MR blood pool agent.
    Adzamli K; Dorshow RB; Hynes MR; Nosco DL; Adams MD
    Acta Radiol Suppl; 1997; 412():73-8. PubMed ID: 9240084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethyleneglycol-stabilized manganese-substituted hydroxylapatite as a potential contrast agent for magnetic resonance imaging: particle stability in biologic fluids.
    Fallis S; Beaty-Nosco J; Dorshow RB; Adzamli K
    Invest Radiol; 1998 Dec; 33(12):847-52. PubMed ID: 9851817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese-substituted hydroxyapatites coated with polyethylene glycol diphosphonate: potential blood-pool agents for magnetic resonance imaging.
    Adzamli K; Dorshow RB; Hynes MR; Nosco DL; Beaty-Nosco JA; Fallis S; Galen KP; Levine JA; Nema S; Polta J; Adams MD
    Acad Radiol; 1996 Aug; 3 Suppl 2():S349-52. PubMed ID: 8796601
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and preliminary evaluation of MP-2269: a novel, nonaromatic small-molecule blood-pool MR contrast agent.
    Wallace RA; Haar JP; Miller DB; Woulfe SR; Polta JA; Galen KP; Hynes MR; Adzamli K
    Magn Reson Med; 1998 Nov; 40(5):733-9. PubMed ID: 9797157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism.
    Gale EM; Wey HY; Ramsay I; Yen YF; Sosnovik DE; Caravan P
    Radiology; 2018 Mar; 286(3):865-872. PubMed ID: 29117483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging.
    Martina MS; Fortin JP; Ménager C; Clément O; Barratt G; Grabielle-Madelmont C; Gazeau F; Cabuil V; Lesieur S
    J Am Chem Soc; 2005 Aug; 127(30):10676-85. PubMed ID: 16045355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits.
    Allkemper T; Bremer C; Matuszewski L; Ebert W; Reimer P
    Radiology; 2002 May; 223(2):432-8. PubMed ID: 11997549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium.
    Taupitz M; Schnorr J; Wagner S; Abramjuk C; Pilgrimm H; Kivelitz D; Schink T; Hansel J; Laub G; Hünigen H; Hamm B
    Radiology; 2002 Jan; 222(1):120-6. PubMed ID: 11756715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol.
    Corot C; Violas X; Robert P; Gagneur G; Port M
    Invest Radiol; 2003 Jun; 38(6):311-9. PubMed ID: 12908698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity.
    Port M; Corot C; Violas X; Robert P; Raynal I; Gagneur G
    Invest Radiol; 2005 Sep; 40(9):565-73. PubMed ID: 16118549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
    Li J; Wu C; Hou P; Zhang M; Xu K
    Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
    Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
    Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of portal MR angiography using superparamagnetic iron oxide.
    Knollmann FD; Böck JC; Teltenkötter S; Wlodarczyk W; Mühler A; Vogl TJ; Felix R
    J Magn Reson Imaging; 1997; 7(1):191-6. PubMed ID: 9039614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paramagnetic macrocyclic complexes as contrast agents for MR imaging: proton nuclear relaxation rate enhancement in aqueous solution and in rat tissues.
    Jackels SC; Kroos BR; Hinson WH; Karstaedt N; Moran PR
    Radiology; 1986 May; 159(2):525-30. PubMed ID: 3961187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization.
    Wagner S; Schnorr J; Pilgrimm H; Hamm B; Taupitz M
    Invest Radiol; 2002 Apr; 37(4):167-77. PubMed ID: 11923639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of pulmonary emboli by using MR angiography with MPEG-PL-GdDTPA: an experimental study in rabbits.
    Frank H; Weissleder R; Bogdanov AA; Brady TJ
    AJR Am J Roentgenol; 1994 May; 162(5):1041-6. PubMed ID: 8165978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced magnetic resonance angiography: P792 blood pool agent versus Gd-DOTA in rabbits at 3.0 T versus 1.5 T.
    Herborn CU; Watkins DM; Baumann S; Robert P; Corot C; Runge VM
    Invest Radiol; 2007 Sep; 42(9):622-8. PubMed ID: 17700277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanin-manganese nanoparticles with ultrahigh efficient clearance in vivo for tumor-targeting T
    Xu W; Sun J; Li L; Peng X; Zhang R; Wang B
    Biomater Sci; 2017 Dec; 6(1):207-215. PubMed ID: 29210372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.